I-ACT for Children Selects Advarra as Central IRB
Advarra announced that it has been selected by the Institute for Advanced Clinical Trials for Children (I-ACT for Children) to provide central institutional review board (IRB) services to the organization’s pediatric clinical trial site network. I-ACT for Children is an independent non-profit organization dedicated to the belief that all children deserve innovative medical therapies developed with the same level of urgency and commitment as seen today for adults.
I-ACT for Children seeks to optimize and accelerate biomedical innovation using child-centered clinical trial networks and collaboration with like-minded institutions, trial sponsors, and other stakeholders. I-ACT for Children selected Advarra with the goal of accelerating site startup and supporting timely completion of global pediatric studies.
“Advarra is proud to have been chosen by I-ACT for Children as its central IRB provider. Together, we will help catalyze improvements in pediatric health by contributing to the timely completion of much needed pediatric studies,” said Pat Donnelly, CEO, Advarra.
“Providing central IRB services as part of our site network is an important part of accelerating and enhancing the efficiency of pediatric clinical trials, which is central to our mission,” said Laura Gordon, CEO of I-ACT for Children. “Every child with a medical need deserves the best chance possible; selecting Advarra as the central IRB for our site network underscores our dedication to driving innovation, quality, and urgency as we work to advance medical therapies specifically for children.”
The I-ACT for Children Site Network currently includes 44 U.S. pediatric research sites.
For more information, visit www.advarra.com
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
